It is unlikely that differences in mA3 expression levels and/or its amino acid sequence provide a significant selective advantage in terms of normal development, survival, or fertility, as Apobec3-knockout mice show no increased propensity for tumor development or disease, and both male and female mA3-deficient mice were fertile [40]. This evidence concerns the gene PNMA3 and neoplasm.